AMOLYT PHARMA ANNOUNCES $138 MILLION SERIES C FINANCING LED BY SOFINNOVA PARTNERS AND CO-LED BY INTERMEDIATE CAPITAL GROUP

20222023
Written By Guest User
Guest User
Previous

Ironwood Enters into Definitive Agreement to Acquire VectivBio
Next

DOMAIN THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED WITH DT-9081 IN PHASE I CLINICAL STUDY